|
|
{{if listFind(vars.channel_names, "MSIF News")}} {{endif}}  {{if listFind(vars.channel_names, "MSIF News")}} {{endif}} {{if listFind(vars.channel_names, "MSIF News")}} 
MSIF News
{{endif}}
|
{{if listFind(vars.channel_names, "People With MS News")}} {{endif}}  {{if listFind(vars.channel_names, "People With MS News")}} {{endif}} {{if listFind(vars.channel_names, "People With MS News")}} 
People with MS News
{{endif}}
|
{{if listFind(vars.channel_names, "Research News")}} {{endif}}  {{if listFind(vars.channel_names, "Research News")}} {{endif}} {{if listFind(vars.channel_names, "Research News")}} 
Research News
{{endif}}
|
{{if listFind(vars.channel_names, "MS Society News")}} {{endif}}  {{if listFind(vars.channel_names, "MS Society News")}} {{endif}} {{if listFind(vars.channel_names, "MS Society News")}} 
MS News
{{endif}}
|
|
|
|
Making Connections
|
{{if listFind(vars.channel_names, "MSIF News")}}
|
|
MSIF News
 |
 |
| Summaries of new MSIF activities, events, projects, programmes, resources, publications and more. |
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
|
|
People with MS News
 |
 |
| Summaries of news, views and achievements from people with MS around the world. |
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
|
|
Research News
 |
 |
| Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London. |
Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity
This study on intra-thecal baclofen (a centrally acting muscle relaxant which is administered directly into the spinal fluid to treat spasticity) showed that patients had improved sleep, but that their ability to breath normally overnight was not affected. The authors conclude that this may indicate that the drug acts directly on the spinal nerves, and does not affect the brain.
authors: Bensmail D, Quera Salva MA, Roche N, Benyahia S, Bohic M, Denys P, Bussel B, Lofaso F.
source: Neurology. 2006 Oct 24;67(8):1432-6.
read more
Chronotherapy using Corticosteroids for Multiple Sclerosis Relapses
This study explores the effect of giving steroids to treat acute MS relapses at times that are tailored to the bodies natural rhythms, as the immune system alters at different times of the day and night. The authors conclude that nighttime administration of steroids may be preferable to patients.
authors: Glass-Marmor L, Paperna T, Ben-Yosef Y, Miller A.
source: J Neurol Neurosurg Psychiatry. 2006 Oct 20; [Epub ahead of print]
read more
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
|
|
MS News
 |
 |
Summaries of MS news from websites around the world.
What is happening at your MS society? Please send your news to Lucy Hurst, MSIF's Information and Communications Manager. |
Canadian study finds MS increasing among women
source: MS Society of Canada
Researchers using a Canada-wide database have found that multiple sclerosis in women has approximately tripled over the past 60 years and that the female to male sex ratio now exceeds three women with MS for every one man (3.5:1).
read more
|
{{endif}}
|
|
Tell a friend

The email you subscribed with us is {{print email}}
Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.
If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.
If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here
Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org
|
|